BioCurex, Inc.(fka BOCX)

[i_invest_utrade]

The people with millions to invest in companies like BOCX have tons of people calling them with hair brained ideas.

I just don't think you're being realistic about this. These people enjoy risk when they understand the business because they can chart the future of the industry. You would have to know a luminary in the biotech field who has the money or connections to plop several million into the company.

I'm sure Moro, Gold, and their advisory board know those kind of people, but the industry is saturated with companies attempting just what Biocurex is doing.

In addition, the venture capitalists have tightened up their purses over the past couple years.

Before ELISA-Recaf none of the tests were as applicable to the broad market or the thousands of labs around the world.

The early tests that involved radioactive elements could not be as widely distributed as the later non-radioactive tests.

It is my understanding that the high throughput analyzers at Abbott would be great for a commercial application, but few labs carry these kind of analyzers to verify the data. I think the Abbott relationship was to see if it could be done. It can be done but verify, verify, verify.


Now with ELISA-Recaf there is the chance for peer review (once patents are in place) and wide verification of the biomarker.